Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05109 (
S100A8
)
1,212
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This work aimed to show that an important, yet unrecognized, role of KC chemokine in the liver is regulation of gene expression. KC expression in the liver stimulated three classes of genes in this temporal order: immediate-early genes, proinflammatory genes, and profibrotic genes. Transcription factors
E2F5
and early growth response 1 (EGR1), Ca(2+) signaling molecules
S100A8
and S100A9, and two oxidative stress-induced genes were identified as immediate-early genes of KC. Expression of these genes was stimulated at 3-5-fold increased KC concentrations. Expression of proinflammatory genes was activated 6 h after the immediateearly genes, and they included interleukin-1alpha (IL-1alpha) and IL-1beta. KC receptor gene CXCR2 was also upregulated, suggesting that KC may act through a positive feedback loop. Stimulation of expression of profibrotic genes, including type I collagen, was seen only after the proinflammatory genes were highly expressed for 12 h. KC is a potent regulator of gene expression that proceeds in a sequential manner. Immediate-early genes of KC stimulation were identified. The positive feedback regulation and an increased oxidative stress induced by KC may explain the poor prognosis in liver patients with elevated levels of CXC chemokines.
...
PMID:Mechanism of direct hepatotoxic effect of KC chemokine: sequential activation of gene expression and progression from inflammation to necrosis. 1703 70